News Archive - 2006

ImmBio Therapeutics Ltd is pleased to announce that it has been awarded a Proof of Concept grant by the East of England Development Agency (“EEDEA”)... Read more

ImmunoBiology Ltd (“ImmBio”) has appointed two new non-executives directors to the Board, reconstituted after completion of its Series C funding round... Read more

ImmunoBiology (“ImmBio”), the Cambridge-based anti-infectives vaccine developer has entered into an agreement to apply Scancell’s ImmunoBody™ technology to selected ant-infective targets... Read more